Jubilant Pharmova Ltd - 530019 - Reg. 34 (1) Annual Report
Notice of the 43rd Annual General Meeting and Annual Report for the Financial Year 2020-21 are enclosed.30-08-2021
30-08-2021
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of information regarding 43rd Annual General Meeting of the Company to be held on Wednesday, September 22, 2021 through Video Conferencing/ Other Audio Visual Means26-08-2021
Jubilant Pharmova up 2%, gains focus after Jhunjhunwala buys 20 lakh shares
Rare Enterprises sold 40.25 lakh equity shares at same price26-08-2021
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in ICICI Securities' Virtual ESG Conference, on August 23, 2021. We enclose details of the Investor/ Analyst for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the Virtual Conference. This is for your information and record.21-08-2021
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in a Group Meeting organized by Monarch Networth Capital Limited, on August 17, 2021. We enclose details of the Investor/ Analyst for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the e-conference.16-08-2021
Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.02-08-2021
Buy Jubilant Pharmova; target of Rs 850: ICICI Direct
ICICI Direct is bullish on Jubilant Pharmova has recommended buy rating on the stock with a target price of Rs 850 in its research report dated July 24, 2021.28-07-2021
Jubilant Pharmova Ltd - 530019 - Intimation Of Record Date For The Purpose Of Declaration Of Dividend For The Financial Year 2020-21
We refer to our letter dated June 4, 2021 intimating recommendation by the Board of Directors for a dividend of Rs. 5 (Rupees Five only) per equity share of Re. 1 each for the year ended March 31, 2021. The dividend is subject to approval of the shareholders at the ensuing Annual General Meeting ('AGM'). Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, August 6, 2021 as the Record Date for the purpose of determining names of the Members eligible for the dividend. The dividend, if approved by the shareholders at the ensuing AGM, will be paid/ dispatched on or before October 20, 2021.27-07-2021
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation of our letter dated July 23, 2021, we enclose copies of the Unaudited Consolidated Financial Results for the quarter ended June 30, 2021 published on July 24, 2021 in MINT (English) and HINDUSTAN (Hindi).25-07-2021
Jubilant Pharmova posts Q1 net profit of Rs 160 crore
The company had posted a net profit of Rs 35.39 crore for the year-ago period, Jubilant Pharmova said in a regulatory filing24-07-2021